03:59 PM EDT, 09/13/2024 (MT Newswires) -- Health care stocks advanced late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.2%.

The iShares Biotechnology ETF (IBB) climbed 1.4%.

In corporate news, 22nd Century ( XXII ) shares surged 23%. The company entered a stock sale agreement with certain institutional investors and high net worth individuals for the sale of 6.1 million shares to raise about $3.5 million.

Singular Genomics Systems ( OMIC ) shares skyrocketed 112%. The company said late Thursday it received a non-binding proposal from Deerfield Management to buy all of its shares not already owned by Deerfield for $10 per share in cash.

MBX Biosciences (MBX) shares debuted on the Nasdaq with an opening price of $23 apiece, above the initial public offering price of $16. The stock surged 44% in recent trading.

Immuneering ( IMRX ) shares climbed 43% after the company said a complete or partial response was seen in the first two patients with pancreatic cancer getting IMM-1-104 plus modified gemcitabine/nab-paclitaxel in a phase 2a trial.